DI
SGMT icon

DUMAC Inc’s Sagimet Biosciences SGMT Stock Holding History

DUMAC Inc’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$550K Hold
71,192
– – 0.05% 14
2026
Q1 		$372K Hold
71,192
– – 0.05% 9
2025
Q4 		$421K Buy
+71,192
New +$512K 0.06% 9
2025
Q2 		$572K Sell
75,000
-72,351
-49% -$305K 3.59% 6
2025
Q1 		$480K Sell
147,351
-16,163
-10% -$67.8K 1.92% 9
2024
Q4 		$736K Sell
163,514
-25,880
-14% -$131K 1.14% 7
2024
Q3 		$525K Hold
189,394
– – 1.7% 8
2024
Q2 		$648K Hold
189,394
– – 2.07% 8
2024
Q1 		$1.03M Sell
189,394
-14,729
-7% -$106K 3.72% 7
2023
Q4 		$1.11M Hold
204,123
– – 3.41% 7
2023
Q3 		$1.8M Buy
+204,123
New +$2.72M 4.82% 6

Other funds holding SGMT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

DUMAC Inc's SGMT Position: Q2 2026 in Review

DUMAC Inc held its Sagimet Biosciences (SGMT) position steady in Q2 2026 at 71,192 shares worth $550K. The position accounts for 0.05% of the portfolio, ranked #14.

DUMAC Inc first reported a position in SGMT in Q3 2023 and has held it in 11 quarters since. The position peaked at $1.8M in Q3 2023. 122 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.

  • DUMAC Inc held 71,192 shares of Sagimet Biosciences worth $550K as of Q2 2026.
  • DUMAC Inc left its Sagimet Biosciences share count unchanged in Q2 2026.
  • Sagimet Biosciences made up 0.05% of DUMAC Inc's portfolio in Q2 2026, its #14 holding.
  • DUMAC Inc first reported a position in Sagimet Biosciences in Q3 2023 and has held it in 11 quarters since.
  • DUMAC Inc's Sagimet Biosciences position peaked at $1.8M in Q3 2023.
  • 122 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.

Based on DUMAC Inc's 13F filing for Q2 2026, filed 11 Aug 2026.